Smruthi Organics Limited
BSE: SMRUTHIORG
Prev Close
128
Open Price
131.75
Volume
2,628
Today Low / High
126.1 / 131.75
52 WK Low / High
103 / 169
Range
121 - 133
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 126.9, reflecting a change of -1.1 (-0.85937%). The expected target range on the BSE is 121 - 133. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.
Smruthi Organics Limited Graph
Smruthi Organics Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Smruthi Organics Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 126.90, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 126.90 | 128.17 | 115.35 - 140.99 |
| 129.44 | 103.55 - 155.33 | ||
| 130.71 | 91.49 - 169.92 | ||
| Bearish Scenario | 126.90 | 125.63 | 113.07 - 138.19 |
| 124.36 | 99.49 - 149.23 | ||
| 123.09 | 86.17 - 160.02 |
Overview of Smruthi Organics Limited
ISIN
INE172E01011
Industry
Medical - Pharmaceuticals
Vol.Avg
8,954
Market Cap
1,452,534,201
Last Dividend
1.5
Official Website
IPO Date
2005-06-16
DCF Diff
75.99
DCF
51
Financial Ratios Every Investor Needs
Stock Dividend of SMRUTHIORG
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-06-13 | June 13, 25 | 1.5 | 1.5 | 2025-06-13 | 2025-07-20 | |
| 2024-09-06 | September 06, 24 | 1.5 | 1.5 | 2024-09-06 | 2024-10-14 | |
| 2023-07-28 | July 28, 23 | 2 | 2 | 2023-07-28 | 2023-08-16 | |
| 2022-07-28 | July 28, 22 | 3 | 3 | 2022-07-29 | 2022-09-04 | |
| 2021-07-01 | July 01, 21 | 3 | 3 | 2021-07-02 | 2021-08-14 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 126.01 Cr | 68.60 Cr | 57.40 Cr | 0.4556 | 0.00 Cr | 0.00 Cr | 40.05 Cr | 3.56 Cr | 3.11 | 12.18 Cr | 0.0283 |
| 2024-03-31 | 126.89 Cr | 74.90 Cr | 51.99 Cr | 0.4097 | 4.99 Cr | 0.00 Cr | 6.30 Cr | 3.59 Cr | 3.14 | 11.63 Cr | 0.0283 |
| 2023-03-31 | 140.63 Cr | 93.75 Cr | 46.88 Cr | 0.3333 | 0.57 Cr | 0.00 Cr | 4.93 Cr | 4.13 Cr | 3.61 | 9.93 Cr | 0.0294 |
| 2022-03-31 | 132.91 Cr | 82.16 Cr | 50.75 Cr | 0.3818 | 0.66 Cr | 0.00 Cr | 14.45 Cr | 10.38 Cr | 9.07 | 19.01 Cr | 0.0781 |
| 2021-03-31 | 124.29 Cr | 68.33 Cr | 55.96 Cr | 0.4502 | 0.40 Cr | 0.00 Cr | 23.11 Cr | 17.11 Cr | 14.95 | 28.53 Cr | 0.1376 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.44 Cr | 111.74 Cr | 40.11 Cr | 71.6294 Cr | 16.80 Cr | 16.29 Cr | 28.31 Cr | 47.36 Cr | 0.00 Cr | 0.00 Cr | 0.16 Cr | 31.0758 Cr |
| 2024-03-31 | 0.48 Cr | 118.19 Cr | 48.57 Cr | 69.6187 Cr | 11.90 Cr | 11.42 Cr | 29.78 Cr | 41.25 Cr | 0.81 Cr | 0.00 Cr | 0.13 Cr | 42.0615 Cr |
| 2023-03-31 | 0.59 Cr | 105.64 Cr | 37.48 Cr | 68.1569 Cr | 5.70 Cr | 5.11 Cr | 23.99 Cr | 38.95 Cr | 0.04 Cr | 0.28 Cr | 0.22 Cr | 35.4761 Cr |
| 2022-03-31 | 0.24 Cr | 87.61 Cr | 20.45 Cr | 67.1615 Cr | 2.82 Cr | 2.58 Cr | 19.93 Cr | 34.12 Cr | 0.05 Cr | 2.69 Cr | 0.14 Cr | 15.6002 Cr |
| 2021-03-31 | 16.14 Cr | 91.82 Cr | 31.33 Cr | 60.4918 Cr | 10.42 Cr | -5.72 Cr | 18.13 Cr | 31.82 Cr | 0.36 Cr | 0.00 Cr | 0.12 Cr | 26.1317 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 9.9762 Cr | -11.4208 Cr | 1.4008 Cr | -1.5388 Cr | -0.0438 Cr | 0.4357 Cr | -11.5151 Cr | 3.5629 Cr | 5.0762 Cr | -1.7169 Cr | 1.4697 Cr |
| 2024-03-31 | 4.4009 Cr | -7.1632 Cr | 3.6341 Cr | -3.8359 Cr | -0.1068 Cr | 0.4795 Cr | -8.2368 Cr | 3.5903 Cr | 6.0700 Cr | -2.2893 Cr | -5.7865 Cr |
| 2023-03-31 | 12.1051 Cr | -10.2453 Cr | -1.5180 Cr | 2.6386 Cr | 0.3418 Cr | 0.5863 Cr | -9.4665 Cr | 4.8691 Cr | 0.6320 Cr | -3.4339 Cr | -4.0569 Cr |
| 2022-03-31 | 2.1746 Cr | 7.1488 Cr | -12.1084 Cr | -4.3792 Cr | -2.7851 Cr | 0.2445 Cr | -6.5538 Cr | 13.7717 Cr | -7.1982 Cr | -3.4339 Cr | -1.8039 Cr |
| 2021-03-31 | 22.8211 Cr | -3.3961 Cr | -6.8555 Cr | 18.9251 Cr | 12.5695 Cr | 16.1421 Cr | -3.8960 Cr | 24.0550 Cr | -5.7622 Cr | 0.0000 Cr | -1.0438 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 18.99 Cr | 8.91 Cr | 10.09 Cr | 0.5311 | -1.18 Cr | -1.10 Cr | -0.96 | 0.32 Cr | -0.0577 |
| 2025-03-31 | 38.09 Cr | 22.31 Cr | 15.79 Cr | 0.4145 | 3.18 Cr | 2.23 Cr | 1.95 | 4.55 Cr | 0.0585 |
| 2024-12-31 | 31.25 Cr | 14.92 Cr | 16.33 Cr | 0.5225 | 2.79 Cr | 1.48 Cr | 1.29 | 4.17 Cr | 0.0474 |
| 2024-09-30 | 29.39 Cr | 15.25 Cr | 14.14 Cr | 0.4812 | 1.56 Cr | 0.78 Cr | 0.68 | 2.90 Cr | 0.0264 |
| 2024-06-30 | 27.27 Cr | 21.07 Cr | 6.21 Cr | 0.2275 | -0.85 Cr | -0.92 Cr | -0.81 | 0.45 Cr | -0.0338 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.44 Cr | 0.07 Cr | 0.51 Cr | 32.47 Cr | 28.31 Cr | 63.33 Cr | 47.36 Cr | 111.74 Cr | 40.11 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 0.75 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -67.78 Cr |
| 2024-09-30 | 0.65 Cr | 0.12 Cr | 0.77 Cr | 22.46 Cr | 33.21 Cr | 60.09 Cr | 45.77 Cr | 107.51 Cr | 39.73 Cr |
| 2024-06-30 | -0.57 Cr | 1.15 Cr | 0.57 Cr | 0.00 Cr | 0.00 Cr | 0.57 Cr | 0.00 Cr | 0.00 Cr | -69.62 Cr |
| 2024-03-31 | 0.57 Cr | 0.15 Cr | 0.57 Cr | 41.03 Cr | 29.78 Cr | 75.42 Cr | 41.06 Cr | 118.19 Cr | 48.57 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.23 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 1.48 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 0.78 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | -0.92 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 1.52 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2021-03-16 | March 16, 21 | 3:1 |
| 2021-03-10 | March 10, 21 | 3:1 |
Similar Stocks: Medical - Pharmaceuticals
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| MedPlus Health Services Limited | MEDPLUS | ₹741.80 | ₹88,825,874,435.00 | ₹95,115.00 |
Key Executives
Gender: female
Year Born:
Gender: male
Year Born: 1958
Gender: male
Year Born:
Gender: male
Year Born: 1984
FAQs about Smruthi Organics Limited
The CEO is Purushotham Malaiah Eaga.
The current price is ₹126.90.
The range is ₹103-169.
The market capitalization is ₹145.25 crores.
The dividend yield is 1.18%.
The P/E ratio is 42.71.
The company operates in the Healthcare sector.
Overview of Smruthi Organics Limited (ISIN: INE172E01011) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹145.25 crores and an average daily volume of 8,954 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹1.5.